googlemarker
Open An Account
Secure With Us
Trade on Mobile

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 393117.53 Face Value (Rs.) : 2 House : Lupin
BSE872.0513 (+1.51 %)
PREV CLOSE (Rs.) 859.05
OPEN PRICE (Rs.) 860.00
BID PRICE (QTY) 870.80 (183)
OFFER PRICE (QTY) 871.65 (168)
VOLUME 160857
TODAY'S LOW / HIGH (Rs.)858.40 883.00
52 WK LOW / HIGH (Rs.)723.55 1090
NSE876.6515.9 (+1.85 %)
PREV CLOSE( Rs. ) 860.75
OPEN PRICE (Rs.) 860.70
BID PRICE (QTY) 876.25 (110)
OFFER PRICE (QTY) 876.65 (24)
VOLUME 1937244
TODAY'S LOW / HIGH(Rs.) 857.50 883.20
52 WK LOW / HIGH (Rs.)723.65 1090
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
1402.75
Dividend Yield(%)
0.58
TTM EPS (Rs.)
31.40
P/E Ratio
27.68
Book Value (Rs.)
353.92
Face Value (Rs.)
2
MCap (Rs. in Mn)
393117.53
Price/Earning (TTM)
21.61
Price/Sales (TTM)
3.96
Price/Book (MRQ)
2.46
PAT Margin (%)
13.33
ROCE (%)
11.72
Incorporation Year : 01-03 1983

Management Info :

Manju D Gupta - Chairman Nilesh Deshbandhu Gupta - Managing Director

Registered Office :

Address : Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone : 022 6640 2323

Website : www.lupinworld.com

Registrars Details :

Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
18Sep Announcement under Regulation 30 (LOD
Lupin appoints Alok Sonig as CEO - US Generics and Global Head - Generic..
17Sep Lupin informs about press release
Lupin has informed about press release titled ‘Lupin appoints Dr. Kamal..
17Sep Announcement under Regulation 30 (LOD
Lupin appoints Dr. Kamal K. Sharma as Advisor to the Company.
QTR Jun 18 ANNUAL 18
Net Profit4294.813446.6
Gross Profit 5621.5 17939.3
Operating Profit 6738.8 22169.8
Net Sales 25791.1 100881.8
Rs. in Millions
Sanofi India (BSE)
img  6525.00 (1.74%)
M.Cap (Rs. in Cr)15027.48
Dr. Reddys Lab (BSE)
img  2604.00 (2.03%)
M.Cap (Rs. in Cr)43226.71
Biocon (BSE)
img  693.20 (4.20%)
M.Cap (Rs. in Cr)41280.00
Aurobindo Pharma (BSE)
img  755.00 (3.36%)
M.Cap (Rs. in Cr)44066.11
PROMOTERS
47.01%
NON-INSTITUTION
15.1%
MUTUAL FUNDS/UTI
6.21%
FI/BANKS/INSURANCE
5.48%
GOVERNMENT
0.25%
FII
0%
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ 230012635 | 
  • BSE - INZ 010012839 | 
  • MCX - INZ000026431  | 
  • NCDEX - INZ000026431  | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • © Copyright 2015. SATCO CAPITAL MARKETS LTD. || Designed Developed & Content Powered By Accord Fintech Pvt.Ltd.
VISIT COUNT     1098132